Yazar "Aksu, Salih" için listeleme
-
Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
Serefhanoglu, Songul; Buyukasik, Yahya; Goker, Hakan; Sayinalp, Nilgun; Haznedaroglu, Ibrahim Celalettin; Aksu, Salih; Ozdemir, Evren (Pergamon-Elsevier Science Ltd, 2010)… -
The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia
Aksu, Salih; Sahin, Fahri; Uz, Burak; Yavuz, Selim A.; Atay, Hilmi; Kelkitli, Engin; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2012)We report our experience in 41 patients with chronic phase (CF)-chronic myeloid leukemia (CML) who had discontinued imatinib switched to dasatinib, retrospectively. The CF-CML patients received dasatinib at starting dose ... -
Filgrastim ve lenograstimin sağlıklı donörlerde periferik kan kök hücre mobilizasyonu üzerine etkilerinin karşılaştırılması
Uz, Burak; Göker, Hakan; Büyükaşık, Yahya; Aksu, Salih; Sayınalp, Nilgün; Haznedaroğlu, C. İbrahim; Özcebe, İ. Osman (2013)Amaç: Granülosit koloni-uyarıcı faktör (G-CSF) nötro-peni tedavisinde ve otolog ve allojeneik transplantasyon öncesi periferik kan kök hücre mobilizasyonunda yaygın olarak kullanılmaktadır. Nötropeninin süresini kısaltır ... -
Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan, Umit Y.; Aksu, Salih; Aktimur, Sude H.; Atay, Hilmi; Bektas, Ozlen; Buyukasik, Yahya; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2015)Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ... -
Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
Aksu, Salih; Ayyildiz, Orhan; Etgul, Sezgin; Goker, Hakan; Gunes, Gursel; Haznedaroglu, Ibrahim C.; Unal, Ali (Akad Doktorlar Yayinevi, 2016)Phosphatidylinositol 3-kinases (PI3Ks) are considered as lipid kinases that are very active in the pathobiology of lymphoproliferative disorders (LPDs). Idelalisib, a selective inhibitor of the delta isoform of PI3K, ... -
In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract
Akkoc, Nefise; Akcelik, Mustafa; Haznedaroglu, Ibrahim C.; Goker, Hakan; Turgut, Mehmet; Aksu, Salih; Firat, H. Cahit (Ortadogu Ad Pres & Publ Co, 2009)Objective: The medicinal value of plants lies in some chemical substrates that produce a definitive physiological action on the human body. Ankaferd comprises a standardized mixture of the plants Thymus vulgaris, Glycyrrhiza ...
